HeadOffice@CellsPower.com
+81-3-6403-9242
HeadOffice@CellsPower.com
+81-3-6403-9242

Alexander Alexandrovich Maximov

Proposed the "stem cell" in 1908 Developed the hypothesis about the existence of "polublasts" in 1924

1908-1924

The Medical Radiological Research center (MRRc) is established in Obnisk, Russia.

1954

Scientists Ernest McCulloch and James Till reveal the clonal nature of bone marrow cells.

1963

Alexander Yakovlevich

Alexander Yakovlevich Friedenstein Discovers Mesenchymal Stem cells

1969

Dr. Anatoly Konoplyannikov

Dr. Anatoly Konoplyannikov becomes the Head of Cell and Experimental Raidology Therapy Department the MRRc in obnisk. Begins BM-Msc Human clinical Trials:

1200+ Clinical Trials at MRRC 
2500+ Clinical Trials Internationally
Awarded 20+ medical patents

1974- Present

AV-Cells Company is Founded

CEO Alexei Gladkov establishes AV-Cells in Singapore in 2011.

He begins to adapt BM-MSC technology from the MRRC for SE-Asia market [November]

Company obtains special extended flight delivery technology [October 2012]

2011

Novena Singapore Lab is established [August]

2013

Kintaro Cells Power is founded in Japan in 2014.

Kintaro Cells Power is founded in Japan in 2014.
200+ new successful treatments preformed
Cells Production lab moved to Ginza, Tokyo

2014

Corporate Expansion

Official registration Cells Power office
in Vietnam [March 10th]
in Malaysia [June 1st]
in Thailand [July 1st]


International Brand Launch event of Kintaro Cells [October 1st]
Cells Production lab moved to Ginza, Tokyo [November 1st]
The 1st Vietnamese Consulting Center of Cells Power Japan was opened on in Hanoi [November 20th]

2016

Cambodia and Dubai Branch offices were registered [March 1st]

2017

Future Goals SALES IN SE-ASIA

Take paper permission for Kintaro Cells in Vietnam, Malaysia, Indonesia, Cambodia through Joint Ventures set up with strong local medical centers


Continue B2B sales and medical tourism to continue standard cash flow

 

COLLABORATION IN JAPAN

Branch into Immune Therapy market through collaboration with Japanese oncological cancer treatment centers and laboratories

Develop our own Immune cells therapy production "Kintaro Immune cells" with full government permission 

Strengthen network of clinics,universities, and sales agents

2018

Future Goals DEVELOPMENT IN SE-ASIA

 

Lab expansion: Using the same technology & methods from our Tokyo lab, we set up local production labs across the region 

Taking permisson for clinical trials in other countries across SE-Asia

THE DOORS TO JAPAN HAVE OPENED
for select disease treatments. Boost of inbound medical tourism to Japan Domestic sales

BRAND AWARENESS BY SALES
"Kintaro" brand of BM-MSC, Immune Cells, and Enriched Medium is common term is SE-Asia and Japan. Brand power increases by collecting more cellular products.

2020

Future Goals

INTERNATIONAL EXPANSION
Create new offices, labs, and networks of clinics throughout China, the Middle East, and other locations

JAPAN EXPANSION
Upgrade office and laboratory to larger location to meet rising demand.

Control a market of +100 clinics/hospitals who use our product within Japan

2022